Comparison of the effects of insulin monotherapy and combination therapy with ipragliflozin and insulin on glucose toxicity in type 2 diabetes mellitus : a randomized controlled trial
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Ipragliflozin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Apr 2017 Planned End Date changed from 31 Mar 2017 to 31 Mar 2018.
- 04 Nov 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan record.
- 04 Sep 2015 New trial record